Literature DB >> 5319286

Impairment of sympathetic transmission by botulinum toxin.

M J Rand, B C Whaler.   

Abstract

Mesh：

Substances：

Year:  1965        PMID： 5319286     DOI： 10.1038/206588a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  9 in total

Review 1.  Treatment of chronic low back pain with botulinum neurotoxins.

Authors:  Bahman Jabbari
Journal:  Curr Pain Headache Rep       Date:  2007-10

Review 2.  Evidence based medicine in the use of botulinum toxin for back pain.

Authors:  B Jabbari
Journal:  J Neural Transm (Vienna)       Date:  2008-03-25       Impact factor: 3.575

Review 3.  [Use of intracutaneous or subcutaneous botulinum toxin for postherpetic neuralgia].

Authors:  L Halb; B J Amann; H Bornemann-Cimenti
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

4.  Postganglionic paralysis of the guinea-pig hypogastric nerve-vas deferens preparation by Clostridium botulinum type D toxin.

Authors:  D A Westwood; B C Whaler
Journal:  Br J Pharmacol Chemother       Date:  1968-05

Review 5.  Release of noradrenaline from the sympathetic postganglionic fibre.

Authors:  J H Burn
Journal:  Br Med J       Date:  1967-04-22

6.  Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord.

Authors:  H Bigalke; I Heller; B Bizzini; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

7.  The effect of physostigmine on the contraction of the retractor penis muscle of the dog in response to sympathetic stimulation.

Authors:  A K Armitage; J H Burn
Journal:  Br J Pharmacol Chemother       Date:  1967-02

8.  Action of botulinum toxin on transmission from sympathetic nerves to the vas deferens.

Authors:  M E Holman; N C Spitzer
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

Review 9.  Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins.

Authors:  Sara M Schaefer; Christopher H Gottschalk; Bahman Jabbari
Journal:  Toxins (Basel)       Date:  2015-07-14       Impact factor: 4.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.